TXN
39
3
TAP
45
-5
NRG
80
3
CB
46
-2
HIG
72
2
V
60
2
EA
70
3
TRIP
66
-7
CINF
53
2
LEN
60
4
WEC
48
2
MTCH
55
5
PVH
69
5
DNB
36
4
NEE
62
2
NTAP
73
6
NDAQ
49
7
EXPE
43
-21
A
48
4
O
44
2
TXN
39
3
TAP
45
-5
NRG
80
3
CB
46
-2
HIG
72
2
V
60
2
EA
70
3
TRIP
66
-7
CINF
53
2
LEN
60
4
WEC
48
2
MTCH
55
5
PVH
69
5
DNB
36
4
NEE
62
2
NTAP
73
6
NDAQ
49
7
EXPE
43
-21
A
48
4
O
44
2
Financhill
Back

CSPC Pharmaceutical Group 10K Form

Buy
66

CSPCY
CSPC Pharmaceutical Group

Last Price:
3.44
Seasonality Move:
6.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CSPCY News And Ratings

See the #1 stock for the next 7 days that we like better than CSPCY

CSPCY Financial Statistics

Sales & Book Value

Annual Sales: $4.45B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.57
Price / Book: 2.18

Profitability

EPS (TTM): 0.27990
Net Income (TTM): $830.87M
Gross Margin: $3.14B
Return on Equity: 18.27%
Return on Assets: 13.4%

CSPC Pharmaceutical Group Earnings Forecast

Key CSPC Pharmaceutical Group Financial Ratios

  • The Gross Profit Margin over the past 21 years for CSPCY is 70.51%.
  • The Selling, General & Administrative Expenses for CSPCY have been equal to 32.85% of Gross Profit Margin.
  • The Research & Development expenses have been 15.36% of Revenue.
  • The Interest Expense is 0.44% of Operating Income.
  • The Net Earning history of CSPCY is 18.68% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 14 years.

CSPC Pharmaceutical Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CSPCY
Website: cspc.com.hk

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 2.63
Quick Ratio: 2.32

Price-to-Earnings

Trailing P/E Ratio: 12.3
Forward P/E Ratio: 0

CSPCY Technical Analysis vs Fundamental Analysis

Buy
66
CSPC Pharmaceutical Group (CSPCY) is a Buy

Is CSPC Pharmaceutical Group a Buy or a Sell?